Nephrology
News, opinions and meeting coverage in nephrology.
β Real-world data on empagliflozin, canagliflozin, and dapagliflozin
Latest in Nephrology
VA researchers found lower risks for 42 diverse outcomes and increased risks for 19 others
And 40.5% noted efficacy claims not listed on the labels of their originator products
25 drugs chosen so far comprise about a third of Medicare Part D spending on prescription drugs
Dual diagnosis comes with increased risks of mortality, heart failure hospitalization
25 drugs chosen so far comprise about a third of Medicare Part D spending on prescription drugs
Dual diagnosis comes with increased risks of mortality, heart failure hospitalization
Nephrology Case Studies
Consider metastatic or ectopic calcification in diagnosing unexplained symptoms in ESRD patients
Surgery had beneficial role
Lab tests, physical exam not helpful -- but history-taking offers a clue
More in Nephrology
Also in TTHealthWatch: catheter material for PICC lines
Significant link only seen in mothers-to-be who had ever smoked
Study suggests subtle, unintentional interpersonal slights are not so benign
But emulated trial found more myocardial infarctions than with bisphosphonate users
Treatment tied to higher recovery odds and faster time to kidney recovery
Metformin and glyburide fell short of achieving noninferiority with insulin
While better than usual care, only some achieved a clinically important difference
Macitentan/tadalafil and sotatercept approvals shifted the field, but by how much seems to differ
Research should be interpreted cautiously, says researcher
Test advocates awaiting more details from CMS on its coverage policy
Researchers recommend close kidney function monitoring in hospitalized patients
